Previous close | 4.8300 |
Open | 4.8700 |
Bid | 0.0000 x 3000 |
Ask | 0.0000 x 3100 |
Day's range | 4.7470 - 5.0100 |
52-week range | 4.4100 - 26.7500 |
Volume | |
Avg. volume | 4,650,370 |
Market cap | 2.047B |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.4800 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.83 |
Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Comprehensive Analysis of Agilon Health's First Quarter Financials and Strategic Initiatives
AUSTIN, Texas, May 07, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2024.